2013
DOI: 10.1038/pr.2013.85
|View full text |Cite
|
Sign up to set email alerts
|

Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination

Abstract: BackgroundChildren with sickle cell disease (SCD) are susceptible to recurrent infections, which are often life threatening and necessitate frequent vaccinations. Given the altered baseline immunity and proinflammatory state associated with SCD, we sought to determine the relative safety and efficacy of vaccination in transgenic SCD mice.MethodsEight week-old SCD mice were vaccinated with ovalbumin (OVA) and aluminum hydroxide weekly for three weeks by the intraperitoneal (IP) or intramuscular (IM) route. One … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 28 publications
(36 reference statements)
1
18
0
Order By: Relevance
“…Histopathology and immunophenotyping suggests that naïve SCD mice exist in a pro-inflammatory immune state, in agreement with previous reports from our laboratory 25,26 and that of other groups in both mouse models 37,38 and in humans with SCD 39 . The immune system in SCD may be primed to respond aggressively to inhaled allergen by virtue of this pro-inflammatory state, providing one explanation for the high morbidity and mortality seen in SCD patients with asthma.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Histopathology and immunophenotyping suggests that naïve SCD mice exist in a pro-inflammatory immune state, in agreement with previous reports from our laboratory 25,26 and that of other groups in both mouse models 37,38 and in humans with SCD 39 . The immune system in SCD may be primed to respond aggressively to inhaled allergen by virtue of this pro-inflammatory state, providing one explanation for the high morbidity and mortality seen in SCD patients with asthma.…”
Section: Discussionsupporting
confidence: 92%
“…Our group has previously reported an altered baseline immunophenotype in the serum, gut, and spleen of SCD mice 25 , raising speculation that disruption in SCD splenic lymphofollicular morphology results in impaired systemic immunity. Furthermore, we have shown sensitization with systemically administered ovalbumin (OVA)/alum leads to increased mortality, antigen-specific serum IgE, and BAL fluid IL-6, and IL-1β 26 . Additionally, Nandekar et al demonstrated histopathological evidence of enhanced pulmonary inflammation in SCD mice under an experimental asthma protocol 27 .…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, several reports [9, 10, 11, 15] by different groups have shown increased mortality, lung histopathology, and eosinophilia in SCD mice when compared to WT mice in the OVA model. Neither a high nor a low dose of HDM resulted in a difference between the genotypes in terms of these inflammatory outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…These mice also exhibit greater airway hyperreactivity (increased airway resistance after methacholine challenge) than WT mice with AAD, as measured by plethysmography [11]. Other consistent findings between humans and mice with SCD and asthma include high levels of allergen-induced immunoglobulin E (IgE) and Th2 cytokines in both the blood and respiratory mucosa [10-15]. …”
Section: Introductionmentioning
confidence: 99%
“…Following the identification of a heightened systemic inflammatory state in SCD mice and humans, studies evaluated organ‐specific profiles for injury, with a particular focus on inflammatory and oxidative stress markers in SCD mice models . Although the lungs are a well‐known target of injury in SCD, there is limited knowledge of the airway inflammatory markers in sickle cell lung disease and are largely based on murine studies (Table ) and vary based on the antigen used to study immune responses . While low dose LPS challenge was associated with elevated levels of TNFα, IL‐1β, and soluble VCAM in serum and broncho‐alveolar lavage (BAL) fluid in transgenic sickle cell mice, systemic OVA challenge (intraperitoneal or intramuscular injections) was associated with increased serum IgE, increased IL‐6, and IL‐1β, in BAL and airway tone, in the absence of histological changes in transgenic SCD mice .…”
Section: Sickle Cell Disease Acute Chest Syndrome and Asthmamentioning
confidence: 99%